Use of systemic proteasome inhibition as an immune-modulating agent in disease.

Use of systemic proteasome inhibition as an immune-modulating agent in disease.

Item
http://www.wikidata.org/entity/Q36754730
Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.Proteasome inhibition activates the mitochondrial pathway of apoptosis in human CD4+ T cells.Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis.The effect of bortezomib on expression of inflammatory cytokines and survival in a murine sepsis model induced by cecal ligation and puncture.Proteasome inhibitor bortezomib suppresses nuclear factor-kappa B activation and ameliorates eye inflammation in experimental autoimmune uveitisInhibition of Proteasome Activity by Low-dose Bortezomib Attenuates Angiotensin II-induced Abdominal Aortic Aneurysm in Apo E(-/-) Mice.Concise review: role and function of the ubiquitin-proteasome system in mammalian stem and progenitor cells.Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo.Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function.Calcium fructoborate--potential anti-inflammatory agent.Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies.In vitro effects of calcium fructoborate upon production of inflammatory mediators by LPS-stimulated RAW 264.7 macrophages.Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells.
P2860

Use of systemic proteasome inhibition as an immune-modulating agent in disease.

Item
http://www.wikidata.org/entity/Q36754730
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Use of systemic proteasome inhibition as an immune-modulating agent in disease.
@ast
Use of systemic proteasome inhibition as an immune-modulating agent in disease.
@en
type
label
Use of systemic proteasome inhibition as an immune-modulating agent in disease.
@ast
Use of systemic proteasome inhibition as an immune-modulating agent in disease.
@en
prefLabel
Use of systemic proteasome inhibition as an immune-modulating agent in disease.
@ast
Use of systemic proteasome inhibition as an immune-modulating agent in disease.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Use of systemic proteasome inhibition as an immune-modulating agent in disease.
@en
P2093
P304
P31
P356
10.2174/187153007780059397
P433
P478
P50
P577
P698